In response to the FDA, Bishop Michael Burbidge, who became the USCCB pro-life chair in November, warned of the dangers to mothers and their unborn children and reaffirmed the Church’s position on life.
The U.S. Catholic bishops are challenging the Biden administration after the U.S. Food and Drug Administration (FDA) announced for the first time that pharmacies can distribute abortion drugs.
“The FDA should protect the life and health of both mothers and children, not loosen safety standards under industry or political pressures,” Bishop Michael Burbidge of Arlington, Virginia, the chair of the bishops’ Committee on Pro-Life Activities, said Friday. “We call on the administration to correct its policy priorities and stand with mothers in need.”
No comments:
Post a Comment